151 related articles for article (PubMed ID: 9129647)
1. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines.
Rimmelzwaan GF; Baars M; van Beek R; van Amerongen G; Lövgren-Bengtsson K; Claas EC; Osterhaus AD
J Gen Virol; 1997 Apr; 78 ( Pt 4)():757-65. PubMed ID: 9129647
[TBL] [Abstract][Full Text] [Related]
2. Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge.
Osterhaus A; de Vries P; Morein B; Akerblom L; Heeney J
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1507-10. PubMed ID: 1466991
[TBL] [Abstract][Full Text] [Related]
3. A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses.
Rimmelzwaan GF; Baars M; van Amerongen G; van Beek R; Osterhaus AD
Vaccine; 2001 Oct; 20(1-2):158-63. PubMed ID: 11567760
[TBL] [Abstract][Full Text] [Related]
4. Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine.
Rimmelzwaan GF; Baars M; van Beek R; de Lijster P; de Jong JC; Claas EC; Osterhaus AD
Vaccine; 1999 Jun; 17(20-21):2512-6. PubMed ID: 10418897
[TBL] [Abstract][Full Text] [Related]
5. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
[TBL] [Abstract][Full Text] [Related]
6. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse.
Paillot R; Prowse L
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):516-21. PubMed ID: 22178272
[TBL] [Abstract][Full Text] [Related]
7. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
[TBL] [Abstract][Full Text] [Related]
8. Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.
Verschoor EJ; Mooij P; Oostermeijer H; van der Kolk M; ten Haaft P; Verstrepen B; Sun Y; Morein B; Akerblom L; Fuller DH; Barnett SW; Heeney JL
J Virol; 1999 Apr; 73(4):3292-300. PubMed ID: 10074183
[TBL] [Abstract][Full Text] [Related]
9. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Paillot R; Grimmett H; Elton D; Daly JM
Vet Res; 2008; 39(3):21. PubMed ID: 18252187
[TBL] [Abstract][Full Text] [Related]
10. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
Osterhaus A; Weijer K; Uytdehaag F; Jarrett O; Sundquist B; Morein B
J Immunol; 1985 Jul; 135(1):591-6. PubMed ID: 2987351
[TBL] [Abstract][Full Text] [Related]
11. Current status and potential application of ISCOMs in veterinary medicine.
Morein B; Hu KF; Abusugra I
Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
[TBL] [Abstract][Full Text] [Related]
12. [Iscom (Immuno Stimulating Complex)-vaccine of equine influenza virus--transmission electron microscopic investigation and literature review].
Brügmann M; Drommer W; Reichl U; Boge A
Dtsch Tierarztl Wochenschr; 1997 Jun; 104(6):196-202. PubMed ID: 9303851
[TBL] [Abstract][Full Text] [Related]
13. Vaccine protection against HIV-2 infection in cynomolgus monkeys.
Putkonen P; Thorstensson R; Walther L; Albert J; Akerblom L; Granquist O; Wadell G; Norrby E; Biberfeld G
AIDS Res Hum Retroviruses; 1991 Mar; 7(3):271-7. PubMed ID: 2064826
[TBL] [Abstract][Full Text] [Related]
14. Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine.
Putkonen P; Björling E; Akerblom L; Thorstensson R; Lövgren K; Benthin L; Chiodi F; Morein B; Biberfeld G; Norrby E
J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):551-9. PubMed ID: 8176640
[TBL] [Abstract][Full Text] [Related]
15. A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.
Ferrantelli F; Maggiorella MT; Schiavoni I; Sernicola L; Olivieri E; Farcomeni S; Pavone-Cossut MR; Moretti S; Belli R; Collacchi B; Srivastava IK; Titti F; Cafaro A; Barnett SW; Ensoli B
Vaccine; 2011 Apr; 29(16):2918-32. PubMed ID: 21338681
[TBL] [Abstract][Full Text] [Related]
16. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.
Lin YL; Yu CI; Hu YC; Tsai TJ; Kuo YC; Chi WK; Lin AN; Chiang BL
Vaccine; 2012 Feb; 30(7):1305-12. PubMed ID: 22214888
[TBL] [Abstract][Full Text] [Related]
17. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
Crouch CF; Daly J; Henley W; Hannant D; Wilkins J; Francis MJ
Vet Immunol Immunopathol; 2005 Dec; 108(3-4):345-55. PubMed ID: 16098611
[TBL] [Abstract][Full Text] [Related]
18. Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses.
Sjölander S; Drane D; Davis R; Beezum L; Pearse M; Cox J
Vaccine; 2001 Jul; 19(28-29):4072-80. PubMed ID: 11427284
[TBL] [Abstract][Full Text] [Related]
19. Influenza virus ISCOMs: antibody response in animals.
Sundquist B; Lövgren K; Morein B
Vaccine; 1988 Feb; 6(1):49-53. PubMed ID: 3354258
[TBL] [Abstract][Full Text] [Related]
20. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]